TABLE 1.
Experimental conditions | PM |
FL |
||||||
---|---|---|---|---|---|---|---|---|
γ | Po | τopen | N; n | γ | Po | τopen | N; n | |
pS | ms | pS | ms | |||||
KvLm | 107 ± 6 | 0.020 ± 0.002 | 1.2 ± 0.2 | 32,796; 10 | 70 ± 3 | 0.07 ± 0.01 | 2.5 ± 0.2 | 27,900; 10 |
KvLm + 5 μm imipramine | 10 ± 2 | 0.67 ± 0.08 | 180 ± 60 | 12,598; 5 | 16 ± 2 | 0.74 ± 0.08 | 100 ± 20 | 19,203; 5 |
KvLm + 1 μm CTX | 15 ± 2 | 0.7 ± 0.1 | 200 ± 50 | 15,642; 5 | 14 ± 3 | 0.7 ± 0.1 | 190 ± 40 | 9,142; 5 |